Schrodinger, Inc. is a leading tech company that endeavors to improve human health by harnessing advanced computational technologies to speed drug discovery and material design. It is a pioneer in the development and application of computational and scientific technology to solve some of the world's most complex health problems.
Listed on NASDAQ under the ticker SDGR, Schrodinger, Inc. was launched in 1990 and is headquartered in New York City, with offices in Boston, London, Munich, Hyderabad, and other locations worldwide. Although its primary focus is drug discovery, Schrodinger's software solutions are also applied to a broad range of scientific research and development, providing innovative solutions to problems and challenges in the life sciences, materials sciences, and chemical industries.
Schrodinger’s proprietary software suite, utilized by researchers worldwide, addresses all aspects of drug discovery through molecular modeling, simulation, and informatics. Their platforms are used to predict the properties of molecules, thereby allowing faster, more efficient research, development, and commercialization of new drugs and materials. The company is responsible for several successful drug discovery and development partnerships, leveraging their unique platforms to support faster, more efficient R&D.
Moreover, this technology also supports material science development through enabling the understanding and optimization of critical properties for materials such as batteries, electronics, and polymers.
Schrodinger’s business model is unique and diversified. It combines its software business with internal drug discovery capabilities and strategic alliances and collaborations with leading pharmaceutical and biotechnology companies. Additionally, the company also makes direct investments in other companies that utilize their platform in drug discovery or materials science.
With over 20 years of investment in research and scientific breakthroughs, Schrodinger, Inc. is well positioned to revolutionize the way we approach drug and material design, and it continues to lead in computing power and scientific advancements that will promote future discoveries and innovations. Through its commitment to pushing the boundaries of scientific research, Schrodinger, Inc. plays a pivotal role in the fight against some of the most challenging diseases, accelerates the discovery timeline, and improves the quality of life for people around the world.